About this trial
The reason for the recognised lack of epidemiological data of all NO conditions presenting to eye departments is attributed to the fact that they often fall in the grey zones between neuro-ophthalmologists, neurosurgeons and neurologists.
. It is anticipated that the findings of the study may then help to support better service planning and resource allocation, as well as identifying any early recognition of rare or emerging patterns.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants aged ≥ 18 years.
Participants seen at the Royal Wolverhampton NHS Trust's Eye Department.
Participants with a diagnosis of NO.
Disqualifiers
Participants aged < 18 years.
Participants who do not have a diagnosis of NO.
Participants who have opted out of their data being used for research (National Data Opt-out).
Trial population
Consecutive patients seen at the Royal Wolverhampton NHS Trust's Eye Department who have a NO diagnosis and meet the eligibility criteria will be selected.
Trial design
Cohort
Prospective
Treatments tested in this trial
No Intervention: Observational Cohort
Other interventionno intervention required
Treatment groups
Trial outcomes
Primary outcomes
Analysis of the incidence and patterns of presentation of common NO conditions compared to other published studies.
Secondary outcomes
Concordance rates between initial and final diagnosis.
Detailed analysis of rare presentations, with a view to share knowledge gained from this in educational meetings.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: